Drug Profile
dl-PHPB
Alternative Names: Potassium 2-(1-hydroxypentyl)-benzoate (PHPB)Latest Information Update: 28 Apr 2019
Price :
$50
*
At a glance
- Originator Institute of Materia Medica
- Class Benzoates
- Mechanism of Action NMDA receptor modulators; Synaptic transmission modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 28 Apr 2019 No recent reports of development identified for phase-I development in Stroke in China
- 01 Mar 2016 Phase-I clinical trials in Stroke in China (unspecified route)